Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.
The report details the trend, potential and market size of Human Coagulation Factor VII market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Coagulation Factor VIImarket, defines the market attractiveness level of Human Coagulation Factor VII market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Coagulation Factor VII industry, describes the types of Human Coagulation Factor VII market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Coagulation Factor VII market and the development prospects and opportunities of Human Coagulation Factor VII industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Coagulation Factor VII market in Chapter 13.
By Player:
NovoNordisk
By Type:
Recombinant Factor VIII
Plasma-derived Factor VIII
By End-User:
Hemophilia Treatment
Surgery
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Coagulation Factor VII Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Coagulation Factor VII Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Coagulation Factor VII Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Coagulation Factor VII Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Coagulation Factor VII Market Analysis and Outlook to 2022
-
7.1 Global Human Coagulation Factor VII Consumption (2017-2022)
-
7.2 United States Human Coagulation Factor VII Consumption (2017-2022)
-
7.3 Europe Human Coagulation Factor VII Consumption (2017-2022)
-
7.4 China Human Coagulation Factor VII Consumption (2017-2022)
-
7.5 Japan Human Coagulation Factor VII Consumption (2017-2022)
-
7.6 India Human Coagulation Factor VII Consumption (2017-2022)
-
7.7 South Korea Human Coagulation Factor VII Consumption (2017-2022)
8 Region and Country-wise Human Coagulation Factor VII Market Analysis and Outlook to 2028
-
8.1 Global Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.2 United States Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.3 Europe Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.4 China Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.5 Japan Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.6 India Human Coagulation Factor VII Consumption Forecast (2022-2028)
-
8.7 South Korea Human Coagulation Factor VII Consumption Forecast (2022-2028)
9 Global Human Coagulation Factor VII Market Outlook by Types and Applications to 2022
-
9.1 Global Human Coagulation Factor VII Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Coagulation Factor VII Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hemophilia Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Human Coagulation Factor VII Market Outlook by Types and Applications to 2028
-
10.1 Global Human Coagulation Factor VII Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Coagulation Factor VII Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Coagulation Factor VII Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Coagulation Factor VII Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Coagulation Factor VII Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Coagulation Factor VII Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Coagulation Factor VII Market Competitive Analysis
-
14.1 NovoNordisk
-
14.1.1 NovoNordisk Company Details
-
14.1.2 NovoNordisk Human Coagulation Factor VII Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NovoNordisk Human Coagulation Factor VII Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Coagulation Factor VII
-
Figure Human Coagulation Factor VII Picture
-
Table Global Human Coagulation Factor VII Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Coagulation Factor VII Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Coagulation Factor VII Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Coagulation Factor VII Consumption by Country (2017-2022)
-
Figure United States Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Table Europe Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Figure China Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Figure India Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Coagulation Factor VII Consumption and Growth Rate (2017-2022)
-
Figure Global Human Coagulation Factor VII Consumption Forecast by Country (2022-2028)
-
Figure United States Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Coagulation Factor VII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma-derived Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plasma-derived Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Coagulation Factor VII Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Coagulation Factor VII Export by Region (Top 5 Countries) (2017-2028)
-
Table NovoNordisk (Foundation Year, Company Profile and etc.)
-
Table NovoNordisk Human Coagulation Factor VII Sales, Price, Value and Gross Profit (2017-2022)
-
Table NovoNordisk Human Coagulation Factor VII Product and Service
-
